Daver, Naval
Schlenk, Richard F.
Russell, Nigel H.
Levis, Mark J.
Article History
Received: 29 August 2018
Revised: 18 October 2018
Accepted: 24 October 2018
First Online: 16 January 2019
Compliance with ethical standards
:
: ND has received research funding from Daiichi Sankyo, Bristol-Myers Squibb, Pfizer, Karyopharm, Sevier, Genentech, and ImmunoGen and has served in a consulting or advisory role for Daiichi Sankyo, Bristol-Myers Squibb, Pfizer, Novartis, Celgene, AbbVie, and Agios. RFS has received honoraria from Daiichi Sankyo, Novartis, Pfizer, Janssen, and Arog; has served in a consulting or advisory role for Daiichi Sankyo, Novartis, and Pfizer; and has received research funding from Pfizer, AstraZeneca, PharmaMar, and Novartis. NHR has received honoraria from and has served in an advisory role for Jazz, Teva, Pfizer, and Daiichi Sankyo. MJL has received honoraria from Daiichi Sankyo, Novartis, and Agios; has served in a consulting or advisory role for Daiichi Sankyo, Novartis, and Agios; and has received research funding from Astellas and Novartis.